In an in vivo model mimicking CF lung disease, knockout of IL-17A led to reduced structural lung damage and decreased levels of lymphocytes, implicating IL-17A and lymphocytes as important mediators of CF lung inflammation (Hagner et al., 2021). This evidence concerns the gene IL17A and cystic fibrosis.